Female and Male Phenotypes of Iron Deficiency in CHF. Additional analysis of the «The Prevalence of Iron Deficiency in Patients With Chronic Heart Failure in the Russian Federation (J-CHF-RF)» study
Aim To evaluate the incidence of iron deficiency (ID) in men and women with chronic heart failure (CHF) and to compare clinical and functional indexes in patient with and without ID depending on the gender.Material and methods An additional analysis of the study "Prevalence of Iron Deficiency in Patients With Chronic Heart Failure in the Russian Federation (ID-CHF-RF)" was performed. The study included 498 (198 women, 300 men) patients with CHF, in whom, in addition to iron metabolism, the quality of life and exercise tolerance (ET) were studied. 97 % of patients were enrolled during their stay in a hospital. ID was defined in consistency with the European Society of Cardiology (ESC) Guidelines. Also, and additional analysis was performed according to ID criteria validated by the morphological picture of the bone marrow.Results ID was detected in 174 (87.9 %) women and 239 (79.8 %) men (p=0.028) according to the ESC criteria, and in 154 (77.8 %) women and 217 (72.3 %) men (p=0.208) according to the criteria validated by the morphological picture of the bone marrow. Men with ID were older and had more severe CHF. They more frequently had HF functional class (FC) III and IV (63.4 % vs. 43.3 % in men without ID); higher concentrations of N-terminal pro-brain natriuretic peptide (NT-proBNP) and lower ET. HF FC III increased the probability of ID presence 3.4 times (p=0.02) and the probability of HF FC IV 13.7 times (p=0.003). This clinical picture was characteristic of men when either method of determining ID was used. In women, ID was not associated with more severe CHF.Conclusion Based on the presented analysis, it is possible to characterize the male and female ID phenotypes. The male ID phenotype is associated with more severe CHF, low ET, and poor quality of life. In females of the study cohort, ID was not associated with either the severity of CHF or with ET.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:63 |
|---|---|
| Enthalten in: |
Kardiologiia - 63(2023), 9 vom: 30. Sept., Seite 3-13 |
| Sprache: |
Russisch |
|---|
| Beteiligte Personen: |
Begrambekova, Yu L [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 01.11.2023 Date Revised 01.11.2023 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.18087/cardio.2023.9.n2413 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM363082832 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM363082832 | ||
| 003 | DE-627 | ||
| 005 | 20231226092608.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||rus c | ||
| 024 | 7 | |a 10.18087/cardio.2023.9.n2413 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1210.xml |
| 035 | |a (DE-627)NLM363082832 | ||
| 035 | |a (NLM)37815134 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a rus | ||
| 100 | 1 | |a Begrambekova, Yu L |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Female and Male Phenotypes of Iron Deficiency in CHF. Additional analysis of the «The Prevalence of Iron Deficiency in Patients With Chronic Heart Failure in the Russian Federation (J-CHF-RF)» study |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.11.2023 | ||
| 500 | |a Date Revised 01.11.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Aim To evaluate the incidence of iron deficiency (ID) in men and women with chronic heart failure (CHF) and to compare clinical and functional indexes in patient with and without ID depending on the gender.Material and methods An additional analysis of the study "Prevalence of Iron Deficiency in Patients With Chronic Heart Failure in the Russian Federation (ID-CHF-RF)" was performed. The study included 498 (198 women, 300 men) patients with CHF, in whom, in addition to iron metabolism, the quality of life and exercise tolerance (ET) were studied. 97 % of patients were enrolled during their stay in a hospital. ID was defined in consistency with the European Society of Cardiology (ESC) Guidelines. Also, and additional analysis was performed according to ID criteria validated by the morphological picture of the bone marrow.Results ID was detected in 174 (87.9 %) women and 239 (79.8 %) men (p=0.028) according to the ESC criteria, and in 154 (77.8 %) women and 217 (72.3 %) men (p=0.208) according to the criteria validated by the morphological picture of the bone marrow. Men with ID were older and had more severe CHF. They more frequently had HF functional class (FC) III and IV (63.4 % vs. 43.3 % in men without ID); higher concentrations of N-terminal pro-brain natriuretic peptide (NT-proBNP) and lower ET. HF FC III increased the probability of ID presence 3.4 times (p=0.02) and the probability of HF FC IV 13.7 times (p=0.003). This clinical picture was characteristic of men when either method of determining ID was used. In women, ID was not associated with more severe CHF.Conclusion Based on the presented analysis, it is possible to characterize the male and female ID phenotypes. The male ID phenotype is associated with more severe CHF, low ET, and poor quality of life. In females of the study cohort, ID was not associated with either the severity of CHF or with ET | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Mareev, Yu V |e verfasserin |4 aut | |
| 700 | 1 | |a Mareev, V Yu |e verfasserin |4 aut | |
| 700 | 1 | |a Orlova, Ya A |e verfasserin |4 aut | |
| 700 | 1 | |a Kobalava, Zh D |e verfasserin |4 aut | |
| 700 | 1 | |a Karapetyan, L V |e verfasserin |4 aut | |
| 700 | 1 | |a Galochkin, S A |e verfasserin |4 aut | |
| 700 | 1 | |a Kazakhmedov, E R |e verfasserin |4 aut | |
| 700 | 1 | |a Lapshin, A A |e verfasserin |4 aut | |
| 700 | 1 | |a Garganeeva, A A |e verfasserin |4 aut | |
| 700 | 1 | |a Kuzheleva, E A |e verfasserin |4 aut | |
| 700 | 1 | |a Efremushkina, A A |e verfasserin |4 aut | |
| 700 | 1 | |a Kiseleva, E V |e verfasserin |4 aut | |
| 700 | 1 | |a Barbarash, O L |e verfasserin |4 aut | |
| 700 | 1 | |a Pecherina, T B |e verfasserin |4 aut | |
| 700 | 1 | |a Galyavich, A S |e verfasserin |4 aut | |
| 700 | 1 | |a Galeeva, Z M |e verfasserin |4 aut | |
| 700 | 1 | |a Baleeva, L V |e verfasserin |4 aut | |
| 700 | 1 | |a Koziolova, N A |e verfasserin |4 aut | |
| 700 | 1 | |a Veclich, A S |e verfasserin |4 aut | |
| 700 | 1 | |a Duplyakov, D V |e verfasserin |4 aut | |
| 700 | 1 | |a Maksimova, M N |e verfasserin |4 aut | |
| 700 | 1 | |a Yakushin, S S |e verfasserin |4 aut | |
| 700 | 1 | |a Smirnova, E A |e verfasserin |4 aut | |
| 700 | 1 | |a Sedykh, E V |e verfasserin |4 aut | |
| 700 | 1 | |a Shaposhnik, I I |e verfasserin |4 aut | |
| 700 | 1 | |a Makarova, N A |e verfasserin |4 aut | |
| 700 | 1 | |a Zemlyanukhina, A A |e verfasserin |4 aut | |
| 700 | 1 | |a Skibitsky, V V |e verfasserin |4 aut | |
| 700 | 1 | |a Fendrikova, A V |e verfasserin |4 aut | |
| 700 | 1 | |a Skibitsky, A V |e verfasserin |4 aut | |
| 700 | 1 | |a Spiropoulos, N A |e verfasserin |4 aut | |
| 700 | 1 | |a Seredenina, E M |e verfasserin |4 aut | |
| 700 | 1 | |a Eruslanova, K A |e verfasserin |4 aut | |
| 700 | 1 | |a Kotovskaya, Yu V |e verfasserin |4 aut | |
| 700 | 1 | |a Tkacheva, O N |e verfasserin |4 aut | |
| 700 | 1 | |a Fedin, M A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Kardiologiia |d 1961 |g 63(2023), 9 vom: 30. Sept., Seite 3-13 |w (DE-627)NLM000007153 |x 0022-9040 |7 nnns |
| 773 | 1 | 8 | |g volume:63 |g year:2023 |g number:9 |g day:30 |g month:09 |g pages:3-13 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.18087/cardio.2023.9.n2413 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 63 |j 2023 |e 9 |b 30 |c 09 |h 3-13 | ||